Eagle Pharmaceuticals had a revenue of 64.65M in the quarter ending Jun 30, 2023, with -2.50%. This bring the company's revenue in the last twelve months to 257.55M, Increased -3.55%. In the fiscal year ending Dec 31, 2022, Eagle Pharmaceuticals had annual revenue of 316.61M with 84.56% growth.